STERIS plc ( STE) - Key Metrics
STE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | ? | ? | ? | ? |
| 2026Q3 | $15.22 | $1.96 | $3.03 | $2.03 |
| 2026Q2 | $14.84 | $1.95 | $2.92 | $2.05 |
| 2026Q1 | $14.14 | $1.80 | $4.27 | $3.32 |
| 2025Q4 | $15.07 | $1.48 | $2.65 | $1.93 |
STE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | ? | ? |
| 2026Q3 | 32.11% | 32.31 |
| 2026Q2 | 32.26% | 31.72 |
| 2026Q1 | 31.68% | 33.31 |
| 2025Q4 | 38.45% | 38.23 |
STE Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q4 | 1.13% | ? |
| 2026Q3 | 0.80% | 0.25% |
| 2026Q2 | 0.83% | 0.25% |
| 2026Q1 | 1.38% | 0.24% |
| 2025Q4 | 0.85% | 0.25% |
STE
List: Contenders
Price: $207
Dividend Yield: 1.17%
Forward Dividend Yield: 1.21%
Payout Ratio: 40.28%
Dividend Per Share: 2.52 USD
Earnings Per Share: 7.93 USD
P/E Ratio: 26.75
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: Ireland
Volume: 489871
Ebitda: 149.1 millionMarket Capitalization: 20.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 22
DGR3: 9.85%
DGR5: 9.03%
DGR10: 9.51%
DGR20: 30.00%